Latest Breaking News On - Davies iqra amin james fischer - Page 1 : comparemela.com

4D pharma plc: 4D Pharma to Present at Upcoming Investor Conferences in March 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) a novel class of drug derived from the microbiome, today announced that 4D management will present at three upcoming investor conferences: Chardan s Virtual 3rd Annual Microbiome Medicines Summit: Monday March 8, 2021 at 11:45 am ET (16:45 GMT). H.C. Wainwright Global Life Sciences Conference: Available on-demand starting Tuesday, March 9, 2021 at 7:00 am ET (12:00 GMT). Oppenheimer s 31 About 4D pharma Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies Live Biotherap

United statesJulie seidelDominic wilson phil walkerNeil hunter michelle boxallBryan garnier coStern investor relations incImage box communicationsExchange commissionMerck co incUnited states securities exchangeLongevity acquisition corporationHc wainwright global life sciences conferenceAnnual microbiome medicines summitMonday marchGlobal life sciences conferenceAnnual healthcare conference